Register
Login:
Share:
Email Facebook Twitter

IXI Share Chat - RSS Feed

Ixico Share Chat (IXI)



Share Price: 45.50Bid: 45.00Ask: 46.00Change: 0.00 (0.00%)No Movement on Ixico
Spread: 1.00Spread as %: 2.22%Open: 48.50High: 48.50Low: 45.50Yesterday’s Close: 45.50


Share Discussion for Ixico (IXI)


Thread ViewThread View
Please Login or Register to post messages
Posts per page:


Pickwick
Posts: 59
Answer
Opinion:No Opinion
Price:48.50
View Thread (2)
RE: AGM
25 Oct '14
Opps, just looked at the RNS's, looks like March time.
 
Pickwick
Posts: 59
Question
Opinion:No Opinion
Price:48.50
View Thread (2)
AGM
25 Oct '14
When is the AGM, that might force out some news here?
testpack3
Posts: 379
Off Topic
Opinion:No Opinion
Price:49.00
View Thread (2)
RE: Phytopharm
16 Sep '14
I bought in end last year on news of collaboration with Chinese re: dementure. A massive problem in China, as elsewhere. Paid 42p and within a few days was well over a pound. Top sliced 50% to get investment back plus some. Happy to hold the freeby shares, but it's going to be a looong wait. I'm sure it is doing all it can on research but will need a breakthrough on drugs, and if approved, no limit to how far sp can go. In MHO
Scottishm24
Posts: 37
Off Topic
Opinion:No Opinion
Price:49.50
View Thread (2)
Phytopharm
11 Sep '14
I bought when Phytopharm so took a massive hit
roger_55
Posts: 12
Observation
Opinion:Sell
Price:49.50
Scottishm24
11 Sep '14
My opinion is to avoid if you hold no shares in IXI and if you can sell without too big a loss do so and invest elsewhere. See testpack3 and my comments below...don't be fooled by large short term rises, the company do not have an income stream and need funding to do "something". When doing your research look at Phytopharm history too...they became Ixico.
Scottishm24
Posts: 37
Off Topic
Opinion:No Opinion
Price:49.50
Any chance?
10 Sep '14
Anyone think this is worth holding onto?
testpack3
Posts: 379
Off Topic
Opinion:No Opinion
Price:50.00
View Thread (2)
RE: Ixico..what is going on?
14 Aug '14
'What does it take to get the sp higher' - simple, an income stream from products which will provide +ve EBITDA.
jarus
Posts: 199
Off Topic
Opinion:Strong Buy
Price:49.50
View Thread (2)
Ixico..what is going on?
31 Jul '14
A few thousand sells and the Mms would drop this share , and all week there have been mostly buys and the share price doesn't move at all...so what is going on...mm's playing silly games? This should be at the 80p level by now and heading to multiply many times over....just like GW pharma, and skyepharma...What does it to take to get the sp higher...a midas tip, perhaps? Strong buy
radar
Posts: 2,059
Off Topic
Opinion:No Opinion
Price:48.50
Roger
30 Jul '14
I could not agree more with you son.

These boards are full of fools, rampers, knaves and faceless jokers.

You have my sympathy but maybe education is never free.
roger_55
Posts: 12
Observation
Opinion:No Opinion
Price:48.50
radar..why
30 Jul '14
66%...very good point! This share was Phytopharm (PYM) and is following a similar pattern...share price goes up, investors pay high price, then down it drops. My PYM, now IXI, shares have lost 94% in 3 yrs and never been above what I paid for them. IXI shares will do the same unless they really develop a product of value otherwise you're just funding the directors...there are far better safer investments on FTSE100!! Just be wary, DYOR and good luck if you believe IXI is worth the investment.



Share Trading BrochureRequest your Free brochures on share dealing, spread betting and CFDs

Sign up for Live Prices
Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.